On behalf of Globe, CRO Limited will run the clinical trial in a unit of a government hospital. Globe received a licence to produce the potential vaccine on Dec 28 last year. The experimental COVID-19 vaccine features in the World Health Organisation’s list of draft landscape of candidate vaccines. The drugmaker shared their effort to produce COVID-19 vaccine in a press briefing on Jul 3 last year and later on Oct 10, said the vaccine ‘has proved its efficacy and safety’ when applied on mice. Initially Globe Biotech had signed an MoU with the icddr,b for running a clinical trial which was later cancelled due to the lack of interest on icddr,b’s part, said Globe Pharmaceuticals Chairman Harunur Rashid.

Source: bd News24 January 17, 2021 08:37 UTC